+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Artificial Insemination Market Size, Share & Trends Analysis Report By End Use (Home, Fertility Clinics & Other Facilities), By Type (Intrauterine, Intravaginal), By Source Type (AIH, AID), And Segment Forecasts, 2019 - 2026

  • ID: 4582089
  • Report
  • June 2019
  • Region: Global
  • 100 pages
  • Grand View Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • GENEA LIMITED
  • HI-TECH SOLUTIONS
  • KITAZATO CORPORATION
  • PRIDE ANGEL
  • ROCKET MEDICAL PLC
  • VITROLIFE
  • MORE
The global artificial insemination market size is expected to reach USD 2.9 billion by 2026 registering a CAGR of 8.4%, according to this report. Over the past few years, infertility has become a major public health concern across the globe. Artificial insemination is usually the preferred first-line treatment to tackle infertility. Lifestyle changes, delay in pregnancy, and hormonal issues are some of the reasons contributing to the rise in fertility-related problems. According to the United Nations, the global fertility rate is expected to decline to 2.2% by 2050. In developing or underdeveloped nations, medical consultation regarding infertility was not easily accessible.

Hence, there was a lack of awareness about available assisted reproductive techniques including artificial or donor insemination and IVF. The average cost of performing an IUI is around USD 865. The success rate for each cycle is around 4 to 5%, which can be increased to about 7 to 16% by consuming fertility drugs. However, older women are not encouraged to go through IUI due to slim chances of success and further complications. Several fertility problems can be addressed through IUI, such as semen allergy, unexplained infertility, and Sexually Transmitted Diseases (STDs).

Further key findings from the study suggest:
  • Artificial insemination is a first-line of infertility treatment, as it is minimally invasive and less expensive as compared to IVF
  • In some countries, such as U.S. and U.K., same-sex couples are provided insurance coverage for artificial insemination procedures
  • Intrauterine insemination held majority of the market share in 2018 and is likely to be the fastest-growing segment over the forecast period as it is the most common and non-invasive procedure
  • Fertility clinics held a majority of the market share in the year 2018 due to higher number of medical facilities offering infertility treatments
  • Europe held a majority of the market share in the year 2018. North America was the second-largest market in 2018
  • Some of the key companies in the global artificial insemination market include Vitrolife, Genea Ltd., Rinovum Women’s Health, LLC, Pride Angel, Hi-Tech Solutions, FUJIFILM Irvine Scientific, Kitazato Corp., and Rocket Medical plc

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • GENEA LIMITED
  • HI-TECH SOLUTIONS
  • KITAZATO CORPORATION
  • PRIDE ANGEL
  • ROCKET MEDICAL PLC
  • VITROLIFE
  • MORE
Chapter 1 Methodology And Scope
1.1 Market Segmentation & Scope
1.1.1 Type
1.1.2 End Use
1.1.3 Source Type
1.1.4 Regional Scope
1.1.5 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased Database
1.3.2 Internal database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume Price Analysis (Model 2)
1.7 List of Secondary Sources
1.8 Objectives
1.8.1 Objective - 1
1.8.2 Objective - 2

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Type
2.2.2 End Use
2.2.3 Source Type
2.2.4 Region
2.3 Competitive Insights

Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Penetration & Growth Prospect Mapping
3.2.1 Penetration Analysis
3.2.2 Market Driver Analysis
3.2.2.1 Constant rise in infertility rate
3.2.2.2 Growing awareness and social acceptance of assisted reproductive technologies
3.2.2.3 Single women and same-sex couples prefer artificial insemination
3.2.3 Market Restraint Analysis
3.2.3.1 Unsupportive government regulations in certain areas
3.3 Artificial insemination Market: Business Environment Analysis Tools

Chapter 4 Artificial Insemination Market: Type Analysis
4.1 Artificial Insemination Type Market Share Analysis, 2018 & 2026
4.2 Artificial insemination Type Market: Segment Dashboard:
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Type Segment
4.3.1 Intrauterine Insemination
4.3.1.1 Intrauterine insemination market, 2015 - 2026 (USD Million)
4.3.2 Intracervical Insemination
4.3.2.1 Intracervical insemination market, 2015 - 2026 (USD Million)
4.3.3 Intravaginal Insemination
4.3.3.1 Intravaginal insemination market, 2015 - 2026 (USD Million)
4.3.4 Intratubal Insemination
4.3.4.1 Intratubal insemination market, 2015 - 2026 (USD Million)

Chapter 5 Artificial Insemination Market: End Use Analysis
5.1 Artificial Insemination End Use Market Share Analysis, 2018 & 2026
5.2 Artificial insemination End Use Market: Segment Dashboard:
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the End Use Segment
5.3.1 Fertility Clinics & Other Facilities
5.3.1.1 Fertility clinics & other facilities market, 2015 - 2026 (USD Million)
5.3.2 HOME
5.3.2.1 home market, 2015 - 2026 (USD Million)

Chapter 6 Artificial Insemination Market: Source Type Analysis
6.1 Artificial Insemination Source Type Market Share Analysis, 2018 & 2026
6.2 Artificial insemination Source Type Market: Segment Dashboard:
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Source Type Segment
6.3.1 AIH-HUSBAND
6.3.1.1 AIH-Husband market, 2015 - 2026 (USD Million)
6.3.2 AID-DONOR
6.3.2.1 AID-Donor market, 2015 - 2026 (USD Million)

Chapter 7 Artificial Insemination Market: Regional Analysis
7.1 Artificial Insemination Regional Market Share Analysis, 2018 & 2026
7.2 Artificial Insemination Regional Market: Segment Dashboard
7.3 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
7.4 Market Size, & Forecasts, and Trend Analysis, 2015 to 2026
7.4.1 North America
7.4.1.1 North America Artificial insemination market, 2015 - 2026 (USD Million)
7.4.1.1.1 U.S.
7.4.1.1.1.1 U.S. Artificial insemination market, 2015 - 2026 (USD Million)
7.4.1.1.2 Canada
7.4.1.1.2.1 Canada Artificial insemination market, 2015 - 2026 (USD Million)
7.4.2 Europe
7.4.2.1 Europe Artificial insemination market, 2015 - 2026 (USD Million)
7.4.2.1.1 U.K.
7.4.2.1.1.1 U.K. Artificial insemination market, 2015 - 2026 (USD Million)
7.4.2.1.2 Germany
7.4.2.1.2.1 Germany Artificial insemination market, 2015 - 2026 (USD Million)
7.4.3 Asia Pacific
7.4.3.1 Asia Pacific Artificial insemination market, 2015 - 2026 (USD Million)
7.4.3.1.1 Japan
7.4.3.1.1.1 Japan Artificial insemination market, 2015 - 2026 (USD Million)
7.4.3.1.2 China
7.4.3.1.2.1 China Artificial insemination market, 2015 - 2026 (USD Million)
7.4.3.1.3 India
7.4.3.1.3.1 India Artificial insemination market, 2015 - 2026 (USD Million)
7.4.4 Latin America
7.4.4.1 Latin America Artificial insemination market, 2015 - 2026 (USD Million)
7.4.4.1.1 Brazil
7.4.4.1.1.1 Brazil Artificial insemination market, 2015 - 2026 (USD Million)
7.4.4.1.2 Mexico
7.4.4.1.2.1 Mexico Artificial insemination market, 2015 - 2026 (USD Million)
7.4.5 Middle East And Africa (MEA)
7.4.5.1 MEA Artificial insemination market, 2015 - 2026 (USD Million)
7.4.5.1.1 South Africa
7.4.5.1.1.1 South Africa Artificial insemination market, 2015 - 2026 (USD Million)

Chapter 8 Competitive Analysis
8.1 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
8.2 Company Profiles
8.2.1 VITROLIFE
8.2.1.1 Company overview
8.2.1.2 Financial performance
8.2.1.3 Product benchmarking
8.2.1.4 Strategic initiatives
8.2.2 GENEA LIMITED
8.2.2.1 Company overview
8.2.2.2 Product benchmarking
8.2.2.3 Strategic initiatives
8.2.3 RINOVUM WOMEN’S HEALTH, LLC
8.2.3.1 Company Overview
8.2.3.2 Product benchmarking
8.2.3.3 STRATEGIC INITIATIVES
8.2.4 PRIDE ANGEL
8.2.4.1 Company overview
8.2.4.2 Product benchmarking
8.2.5 HI-TECH SOLUTIONS
8.2.5.1 Company overview
8.2.5.2 Product benchmarking
8.2.6 FUJIFILM IRVINE SCIENTIFIC
8.2.6.1 Company overview
8.2.6.2 Product benchmarking
8.2.6.3 Strategic initiatives
8.2.7 KITAZATO CORPORATION
8.2.7.1 Company overview
8.2.7.2 Product benchmarking
8.2.7.3 Strategic initiatives
8.2.8 ROCKET MEDICAL PLC
8.2.8.1 Company overview
8.2.8.2 Product benchmarking
Note: Product cover images may vary from those shown
3 of 3
  • VITROLIFE
  • GENEA LIMITED
  • RINOVUM WOMEN’S HEALTH, LLC
  • PRIDE ANGEL
  • HI-TECH SOLUTIONS
  • FUJIFILM IRVINE SCIENTIFIC
  • KITAZATO CORPORATION
  • ROCKET MEDICAL PLC
Note: Product cover images may vary from those shown
Adroll
adroll